메뉴 건너뛰기




Volumn 8, Issue 2, 2006, Pages 95-101

Polyomavirus-associated nephropathy: Update on antiviral strategies

Author keywords

BK; Cidofovir; Fluoroquinolones; Kidney transplantation; Leflunomide; Polyomavirus

Indexed keywords

2 CYANO 3 HYDROXY N [4 (TRIFLUOROMETHYL)PHENYL] 6 HEPTYNAMIDE; ANTIVIRUS AGENT; CEPHALOSPORIN; CIDOFOVIR; CIDOFOVIR DIPHOSPHATE; CIPROFLOXACIN; DRUG METABOLITE; ESTER DERIVATIVE; GATIFLOXACIN; HEXADECYLOXYPROPYL CIDOFOVIR; LEFLUNOMIDE; LEVOFLOXACIN; MALONONITRILAMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NALIDIXIC ACID; NUCLEOSIDE DERIVATIVE; OCTADECYLOXYETHYL CIDOFOVIR; OFLOXACIN; OLEYLOXYETHYL CIDOFOVIR; OXOLINIC ACID; PREDNISONE; PROBENECID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RAPAMYCIN; TACROLIMUS; TERIFLUNOMIDE; TROVAFLOXACIN; UNCLASSIFIED DRUG;

EID: 33744817368     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2006.00150.x     Document Type: Review
Times cited : (66)

References (45)
  • 1
    • 21144443075 scopus 로고    scopus 로고
    • Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations
    • Hirsch HH Brennan DC Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 2005: 79: 1277 1286.
    • (2005) Transplantation , vol.79 , pp. 1277-1286
    • Hirsch, H.H.1    Brennan, D.C.2    Drachenberg, C.B.3
  • 2
    • 33744792393 scopus 로고    scopus 로고
    • National survey of polyoma (BK) virus in renal transplant recipients (RTR)
    • Kadambi P Baliga R Javaid B, et al. National survey of polyoma (BK) virus in renal transplant recipients (RTR). Am J Transplant 2004: 4 Suppl. 8: 586A.
    • (2004) Am J Transplant , vol.4 , Issue.8
    • Kadambi, P.1    Baliga, R.2    Javaid, B.3
  • 3
    • 20044363947 scopus 로고    scopus 로고
    • Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction
    • Brennan DC Agha I Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005: 5: 582 594.
    • (2005) Am J Transplant , vol.5 , pp. 582-594
    • Brennan, D.C.1    Agha, I.2    Bohl, D.L.3
  • 4
    • 0034002940 scopus 로고    scopus 로고
    • BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game
    • Nickeleit V Hirsch HH Zeiler M, et al. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant 2000: 15: 324.
    • (2000) Nephrol Dial Transplant , vol.15 , pp. 324
    • Nickeleit, V.1    Hirsch, H.H.2    Zeiler, M.3
  • 5
    • 0442276340 scopus 로고    scopus 로고
    • Polyomavirus nephropathy: Morphology, pathophysiology, and clinical management
    • Nickeleit V Singh HK Mihatsch MJ. Polyomavirus nephropathy: morphology, pathophysiology, and clinical management. Curr Opin Nephrol Hypertens 2003: 12: 599.
    • (2003) Curr Opin Nephrol Hypertens , vol.12 , pp. 599
    • Nickeleit, V.1    Singh, H.K.2    Mihatsch, M.J.3
  • 6
    • 0142121325 scopus 로고    scopus 로고
    • BK virus nephropathy diagnosis and treatment: Experience at the University of Maryland Renal Transplant Program
    • Ramos E Drachenberg CB Portocarrero M, et al. BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program. Clin Transpl 2002: 143 153.
    • (2002) Clin Transpl , pp. 143-153
    • Ramos, E.1    Drachenberg, C.B.2    Portocarrero, M.3
  • 7
    • 0031037931 scopus 로고    scopus 로고
    • Activities of various compounds against murine and primate polyomaviruses
    • Andrei G Snoeck R Vandeputte M, et al. Activities of various compounds against murine and primate polyomaviruses. Antimicrob Agents Chemother 1997: 41: 587 593.
    • (1997) Antimicrob Agents Chemother , vol.41 , pp. 587-593
    • Andrei, G.1    Snoeck, R.2    Vandeputte, M.3
  • 8
    • 0029000871 scopus 로고
    • Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients
    • Cundy KC Petty BG Flaherty J, et al. Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 1995: 39: 1247 1252.
    • (1995) Antimicrob Agents Chemother , vol.39 , pp. 1247-1252
    • Cundy, K.C.1    Petty, B.G.2    Flaherty, J.3
  • 9
    • 0000072528 scopus 로고    scopus 로고
    • Graft function after diagnosis of BK virus in adult kidney transplant recipients under tacrolimus-based immunosuppression
    • Scantlebury V Shapiro R Justin G, et al. Graft function after diagnosis of BK virus in adult kidney transplant recipients under tacrolimus-based immunosuppression. Am J Transplant 2001: 1 Suppl. 1: 404.
    • (2001) Am J Transplant , vol.1 , Issue.1 , pp. 404
    • Scantlebury, V.1    Shapiro, R.2    Justin, G.3
  • 10
    • 22844436106 scopus 로고    scopus 로고
    • Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients
    • Kuypers DRJ Vandooren A Lerut E, et al. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am J Transplant 2005: 5: 1997 2004.
    • (2005) Am J Transplant , vol.5 , pp. 1997-2004
    • Kuypers, D.R.J.1    Vandooren, A.2    Lerut, E.3
  • 12
    • 12344300330 scopus 로고    scopus 로고
    • Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system
    • Farasati NA Shapiro R Vats A, et al. Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation 2005: 79: 116 118.
    • (2005) Transplantation , vol.79 , pp. 116-118
    • Farasati, N.A.1    Shapiro, R.2    Vats, A.3
  • 13
    • 33645785582 scopus 로고    scopus 로고
    • Ether lipid ester derivatives of cidofovir inhibit polyomavirus BK replication in vitro
    • Randhawa P Farasati NA Shapiro R Hostetler KY. Ether lipid ester derivatives of cidofovir inhibit polyomavirus BK replication in vitro. Antimicrob Agents Chemother 2006: 50: 1564 1566.
    • (2006) Antimicrob Agents Chemother , vol.50 , pp. 1564-1566
    • Randhawa, P.1    Farasati, N.A.2    Shapiro, R.3    Hostetler, K.Y.4
  • 14
    • 12944317148 scopus 로고    scopus 로고
    • Comparison of the antiviral activities of alkoxyalkyl and alkyl esters of cidofovir against human and murine cytomegalovirus replication in vitro
    • Wan WB Beadle JR Hartline C, et al. Comparison of the antiviral activities of alkoxyalkyl and alkyl esters of cidofovir against human and murine cytomegalovirus replication in vitro. Antimicrob Agents Chemother 2005: 49: 656 662.
    • (2005) Antimicrob Agents Chemother , vol.49 , pp. 656-662
    • Wan, W.B.1    Beadle, J.R.2    Hartline, C.3
  • 15
    • 2342578752 scopus 로고    scopus 로고
    • Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice
    • Smee DF Wong MH Bailey KW, et al. Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice. Int J Antimicrob Agents 2004: 23: 430 437.
    • (2004) Int J Antimicrob Agents , vol.23 , pp. 430-437
    • Smee, D.F.1    Wong, M.H.2    Bailey, K.W.3
  • 16
    • 0033565880 scopus 로고    scopus 로고
    • In vivo activity of leflunomide: Pharmacokinetic analyses and mechanism of immunosuppression
    • Chong AS Huang W Liu W, et al. In vivo activity of leflunomide: pharmacokinetic analyses and mechanism of immunosuppression. Transplantation 1999: 68: 100 109.
    • (1999) Transplantation , vol.68 , pp. 100-109
    • Chong, A.S.1    Huang, W.2    Liu, W.3
  • 18
    • 0029808510 scopus 로고    scopus 로고
    • In vivo mechanism of action of leflunomide: Selective inhibition of the capacity of B lymphocytes to make T-independent xenoantibodies
    • Lin Y Waer M. In vivo mechanism of action of leflunomide: selective inhibition of the capacity of B lymphocytes to make T-independent xenoantibodies. Transplant Proc 1996: 28: 3085.
    • (1996) Transplant Proc , vol.28 , pp. 3085
    • Lin, Y.1    Waer, M.2
  • 19
    • 0031906108 scopus 로고    scopus 로고
    • Induction of specific transplantation tolerance across xenogeneic barriers in the T-independent immune compartment
    • Lin Y Goebels J Xia G Ji P Vandeputte M Waer M. Induction of specific transplantation tolerance across xenogeneic barriers in the T-independent immune compartment. Nat Med 1998: 4: 173 180.
    • (1998) Nat Med , vol.4 , pp. 173-180
    • Lin, Y.1    Goebels, J.2    Xia, G.3    Ji, P.4    Vandeputte, M.5    Waer, M.6
  • 20
    • 0028354267 scopus 로고
    • Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine
    • Williams JW Xiao F Foster P, et al. Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine. Transplantation 1994: 57: 1223 1231.
    • (1994) Transplantation , vol.57 , pp. 1223-1231
    • Williams, J.W.1    Xiao, F.2    Foster, P.3
  • 21
    • 0028846444 scopus 로고
    • Pharmacologically induced regression of chronic transplant rejection
    • Xiao F Chong A Shen J, et al. Pharmacologically induced regression of chronic transplant rejection. Transplantation 1995: 60: 1065 1072.
    • (1995) Transplantation , vol.60 , pp. 1065-1072
    • Xiao, F.1    Chong, A.2    Shen, J.3
  • 22
    • 0029917751 scopus 로고    scopus 로고
    • Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation
    • Xiao F Shen J Chong A, et al. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation. Transplant Proc 1996: 28: 691 692.
    • (1996) Transplant Proc , vol.28 , pp. 691-692
    • Xiao, F.1    Shen, J.2    Chong, A.3
  • 24
    • 0033610251 scopus 로고    scopus 로고
    • Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide
    • Waldman WJ Knight DA Lurain NS. Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. Transplantation 1999: 68: 814 825.
    • (1999) Transplantation , vol.68 , pp. 814-825
    • Waldman, W.J.1    Knight, D.A.2    Lurain, N.S.3
  • 25
    • 0343114297 scopus 로고    scopus 로고
    • Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide
    • Waldman WJ Knight DA Blinder L, et al. Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology 1999: 42: 412 418.
    • (1999) Intervirology , vol.42 , pp. 412-418
    • Waldman, W.J.1    Knight, D.A.2    Blinder, L.3
  • 26
    • 33744780534 scopus 로고    scopus 로고
    • Sponsor: Hoechst Marion Roussel. Summary of NDA 20-905
    • Sponsor: Hoechst Marion Roussel. Summary of NDA 20-905. Clini Pharmacol/Biopharm Rev 1998: 31 33.
    • (1998) Clini Pharmacol/Biopharm Rev , pp. 31-33
  • 27
    • 0037083864 scopus 로고    scopus 로고
    • Experiences with leflunomide in solid organ transplantation
    • Williams JW Mital D Chong A, et al. Experiences with leflunomide in solid organ transplantation. Transplantation 2002: 73: 358 366.
    • (2002) Transplantation , vol.73 , pp. 358-366
    • Williams, J.W.1    Mital, D.2    Chong, A.3
  • 28
    • 19944382834 scopus 로고    scopus 로고
    • Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection
    • Avery RK Bolwell BJ Yen-Lieberman B, et al. Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection. Bone Marrow Transplant 2004: 34: 1071 1075.
    • (2004) Bone Marrow Transplant , vol.34 , pp. 1071-1075
    • Avery, R.K.1    Bolwell, B.J.2    Yen-Lieberman, B.3
  • 29
    • 2442717552 scopus 로고    scopus 로고
    • Leflunomide therapy for cytomegalovirus disease in renal allograft recipients
    • John GT Manivannan J Chandy S Peter S Jacob CK. Leflunomide therapy for cytomegalovirus disease in renal allograft recipients. Transplantation 2004: 77: 1460 1461.
    • (2004) Transplantation , vol.77 , pp. 1460-1461
    • John, G.T.1    Manivannan, J.2    Chandy, S.3    Peter, S.4    Jacob, C.K.5
  • 30
    • 33744819810 scopus 로고    scopus 로고
    • The use of leflunomide in virally infected transplant patients
    • Josephson MA Kadambi PV Javaid B, et al. The use of leflunomide in virally infected transplant patients. J Am Soc Nephrol 2004: 15: 523A.
    • (2004) J Am Soc Nephrol , vol.15
    • Josephson, M.A.1    Kadambi, P.V.2    Javaid, B.3
  • 31
    • 20144366719 scopus 로고    scopus 로고
    • Leflunomide for polyomavirus type BK nephropathy
    • Williams JW Javaid B Kadambi PV, et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med 2005: 352: 1157 1158.
    • (2005) N Engl J Med , vol.352 , pp. 1157-1158
    • Williams, J.W.1    Javaid, B.2    Kadambi, P.V.3
  • 32
    • 33645067944 scopus 로고    scopus 로고
    • Treatment of renal allograft polyoma BK virus infection with leflunomide
    • Josephson MA Gillen D Javaid B, et al. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation 2006: 81: 704 710.
    • (2006) Transplantation , vol.81 , pp. 704-710
    • Josephson, M.A.1    Gillen, D.2    Javaid, B.3
  • 34
    • 0031695155 scopus 로고    scopus 로고
    • Moving one DNA double helix through another by a type II DNA topoisomerase: The story of a simple molecular machine
    • Wang JC. Moving one DNA double helix through another by a type II DNA topoisomerase: the story of a simple molecular machine. Q Rev Biophys 1998: 31: 107 144.
    • (1998) Q Rev Biophys , vol.31 , pp. 107-144
    • Wang, J.C.1
  • 35
    • 0018628599 scopus 로고
    • Escherichia coli mutants thermosensitive for deoxyribonucleic acid gyrase subunit A: Effects on deoxyribonucleic acid replication, transcription, and bacteriophage growth
    • Kreuzer KN Cozzarelli NR. Escherichia coli mutants thermosensitive for deoxyribonucleic acid gyrase subunit A: effects on deoxyribonucleic acid replication, transcription, and bacteriophage growth. J Bacteriol 1979: 40: 424 435.
    • (1979) J Bacteriol , vol.40 , pp. 424-435
    • Kreuzer, K.N.1    Cozzarelli, N.R.2
  • 36
    • 0024008972 scopus 로고
    • Antiviral activity of gyrase inhibitors norfloxacin, coumermycin A1 and nalidixic acid
    • Ferrazzi E Peracchi M Biasolo MA, et al. Antiviral activity of gyrase inhibitors norfloxacin, coumermycin A1 and nalidixic acid. Biochem Pharmacol 1988: 37: 1885 1886.
    • (1988) Biochem Pharmacol , vol.37 , pp. 1885-1886
    • Ferrazzi, E.1    Peracchi, M.2    Biasolo, M.A.3
  • 37
    • 0023835787 scopus 로고
    • Topoisomerase II inhibitors influence simian virus 40 chromatin structure in vivo accompanied with inhibition of replication, transcription and changes in DNA supercoiling
    • Waldeck W Zentgraf H Rosl F. Topoisomerase II inhibitors influence simian virus 40 chromatin structure in vivo accompanied with inhibition of replication, transcription and changes in DNA supercoiling. Oncology 1988: 45: 107 116.
    • (1988) Oncology , vol.45 , pp. 107-116
    • Waldeck, W.1    Zentgraf, H.2    Rosl, F.3
  • 38
    • 0025861424 scopus 로고
    • Altered DNA binding and replication activities of JC virus T-antigen mutants
    • Tavis JE Frisque RJ. Altered DNA binding and replication activities of JC virus T-antigen mutants. Virology 1991: 183: 239 250.
    • (1991) Virology , vol.183 , pp. 239-250
    • Tavis, J.E.1    Frisque, R.J.2
  • 39
    • 0034573640 scopus 로고    scopus 로고
    • SV40 large T antigen functions in DNA replication and transformation
    • Simmons DT. SV40 large T antigen functions in DNA replication and transformation. Adv Virus Res 2000: 55: 75 134.
    • (2000) Adv Virus Res , vol.55 , pp. 75-134
    • Simmons, D.T.1
  • 40
    • 0022460253 scopus 로고
    • Transactivation of BKV and SV40 early promoters by BKV and SV40 T-antigens
    • Caputo A Barbanti-Brodano G Wang E, et al. Transactivation of BKV and SV40 early promoters by BKV and SV40 T-antigens. Virology 1986: 152: 459 465.
    • (1986) Virology , vol.152 , pp. 459-465
    • Caputo, A.1    Barbanti-Brodano, G.2    Wang, E.3
  • 41
    • 0023901821 scopus 로고
    • Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase
    • Portolani M Pietrosemoli P Cermelli C, et al. Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase. Antiviral Res 1988: 9: 205 218.
    • (1988) Antiviral Res , vol.9 , pp. 205-218
    • Portolani, M.1    Pietrosemoli, P.2    Cermelli, C.3
  • 42
    • 33744782392 scopus 로고    scopus 로고
    • Anti-BK virus activity of ciprofloxacin and related antibiotics
    • 1366-1367.
    • Randhawa PS. Anti-BK virus activity of ciprofloxacin and related antibiotics. Clin Infect Dis 2005: 41: 1366-1367.
    • (2005) Clin Infect Dis , pp. 41
    • Randhawa, P.S.1
  • 43
    • 33744808075 scopus 로고    scopus 로고
    • Inhibition of polyoma helicase activity by quinolones
    • Ali S Chandraker A DeCaprio J. Inhibition of polyoma helicase activity by quinolones. J Am Soc Nephrol 2003: 14: 43A.
    • (2003) J Am Soc Nephrol , vol.14
    • Ali, S.1    Chandraker, A.2    Decaprio, J.3
  • 44
    • 22544483489 scopus 로고    scopus 로고
    • Use of fluoroquinolones to treat BK infection in renal transplant recipients
    • Chandraker A Ali S Drachenberg CB, et al. Use of fluoroquinolones to treat BK infection in renal transplant recipients. Am J Transplant 2004: 4: 587.
    • (2004) Am J Transplant , vol.4 , pp. 587
    • Chandraker, A.1    Ali, S.2    Drachenberg, C.B.3
  • 45
    • 13944262482 scopus 로고    scopus 로고
    • Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation
    • Leung AY Chan MT Yuen KY, et al. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2005: 40: 528 537.
    • (2005) Clin Infect Dis , vol.40 , pp. 528-537
    • Leung, A.Y.1    Chan, M.T.2    Yuen, K.Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.